BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3168077)

  • 1. Interferon in chronic active hepatitis B. Preliminary results.
    Waked I; Amin M; Abd-el Fattah SA; Osman L; Sabbour M
    Chemioterapia; 1988 Jun; 7(3):198-202. PubMed ID: 3168077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
    Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of intrahepatic localization of hepatitis B core antigen in HBeAg positive patients with chronic active hepatitis B treated with interferon.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Iwai M; Kashima K; Sokawa Y
    Am J Gastroenterol; 1990 Jun; 85(6):660-4. PubMed ID: 2191593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
    Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A
    Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
    Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of antiviral combination therapy in chronic hepatitis B.
    De Man RA; Schalm SW; Heijtink RA; Berk L; Den Ouden J; ten Kate FJ; Chamuleau RA; Reesink HW
    Am J Med; 1988 Aug; 85(2A):150-4. PubMed ID: 3044080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
    Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
    Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
    Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon.
    Schalm SW
    Chemioterapia; 1988 Dec; 7 Suppl 3():26-9. PubMed ID: 3248317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
    Caban J; Mossor-Ostrowska J; Zyrkowska-Bieda T; Zejc M; Janas-Skulina U; Cieśla A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):229-35. PubMed ID: 8129566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz J; Cummins J; Georgiades J
    Przegl Epidemiol; 1991; 45(4):325-30. PubMed ID: 1841411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.